101 related articles for article (PubMed ID: 10025875)
1. Expression of Fas-related genes in human hepatocellular carcinomas.
Shin EC; Shin JS; Park JH; Kim JJ; Kim H; Kim SJ
Cancer Lett; 1998 Dec; 134(2):155-62. PubMed ID: 10025875
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 gene modulates Fas-related death signals and anti-apoptotic functions in hepatocellular carcinoma.
Uesugi K; Hiasa Y; Tokumoto Y; Mashiba T; Koizumi Y; Hirooka M; Abe M; Matsuura B; Onji M
J Gastroenterol; 2013 Sep; 48(9):1069-80. PubMed ID: 23142971
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.
Zou C; Chen J; Chen K; Wang S; Cao Y; Zhang J; Sheng Y; Huang A; Tang H
Exp Cell Res; 2015 Feb; 331(2):352-61. PubMed ID: 25449696
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
6. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
7. Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.
Lee CF; Ling ZQ; Zhao T; Lee KR
World J Gastroenterol; 2008 Oct; 14(39):6072-7. PubMed ID: 18932288
[TBL] [Abstract][Full Text] [Related]
8. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression.
Liu W; Lin YT; Yan XL; Ding YL; Wu YL; Chen WN; Lin X
FASEB J; 2015 Mar; 29(3):1113-23. PubMed ID: 25466893
[TBL] [Abstract][Full Text] [Related]
10. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
15. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
16. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
17. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
18. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
20. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues.
Kobayashi S; Matsushita K; Saigo K; Urashima T; Asano T; Hayashi H; Ochiai T
Cancer; 2001 Jun; 91(11):2096-103. PubMed ID: 11391590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
